EUROMEDICA S.A.
Announcement
Further to its announcements dated 28.12.2007 and 02.01.2008, and pursuant to article 9(5) of Law 3556/2007, EUROMEDICA S.A. hereby announces that on 31.12.2007 the Deputy Minister of the Ministry of Development approved, by means of a relevant decision, the increase in the share capital of EUROMEDICA S.A. resulting from the absorption of the "GENERAL CLINIC OF THESSALONIKI S.A.", the "MEDICAL INSTITUTE OF HIGH TECHNOLOGY OF CRETE S.A." and "EUROMEDICA WEST MACEDONIA S.A." - by the amount of 8,888,420.75 euro, through the issuance of 5,734,465 new ordinary (dematerialised) registered shares with a nominal value of 1.55 euro each. Thus, the company share capital currently amounts to 67,643,271.00 euro divided into 43,640,820 ordinary dematerialised registered shares with a nominal value of 1.55 euro each.
In accordance with the share exchange ratios that have been approved, the shareholders of the first absorbed company (excluding EUROMEDICA S.A.) shall hold 2,753,638 shares (i.e. a percentage of 6.30977603078%) and an equal number of votes, the shareholders of the second absorbed company (excluding EUROMEDICA S.A.) shall hold 935,715 shares (i.e. a percentage of 2.14412790593%) and an equal number of votes, the shareholders of the third absorbed company (excluding EUROMEDICA S.A.) shall hold 410,595 shares (i.e. a percentage of 0.94085079061%) and an equal number of votes and the old shareholders of EUROMEDICA S.A. shall hold 39,540,872 shares (i.e. a percentage of 90.605245272%) and an equal number of votes.
The 5,734,465 new shares shall be listed for trading following the receipt of the relevant approvals by the Athens Stock Exchange and Capital Market Commission, whereas new announcements by the company on the matter shall follow.
In accordance with the share exchange ratios that have been approved, the shareholders of the first absorbed company (excluding EUROMEDICA S.A.) shall hold 2,753,638 shares (i.e. a percentage of 6.30977603078%) and an equal number of votes, the shareholders of the second absorbed company (excluding EUROMEDICA S.A.) shall hold 935,715 shares (i.e. a percentage of 2.14412790593%) and an equal number of votes, the shareholders of the third absorbed company (excluding EUROMEDICA S.A.) shall hold 410,595 shares (i.e. a percentage of 0.94085079061%) and an equal number of votes and the old shareholders of EUROMEDICA S.A. shall hold 39,540,872 shares (i.e. a percentage of 90.605245272%) and an equal number of votes.
The 5,734,465 new shares shall be listed for trading following the receipt of the relevant approvals by the Athens Stock Exchange and Capital Market Commission, whereas new announcements by the company on the matter shall follow.